Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
G Lurje, AE Hendifar, AM Schultheis… - Pharmacogenetics …, 2009 - journals.lww.com
Purpose Identifying molecular markers for tumor recurrence is critical in successfully
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
[PDF][PDF] Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
G Lurje, AE Hendifar, AM Schultheis, A Pohl, H Husain… - academia.edu
Purpose Identifying molecular markers for tumor recurrence is critical in successfully
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
[引用][C] Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
G LURJE, AE HENDIFAR… - … and genomics (Print …, 2009 - pascal-francis.inist.fr
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with
tumor recurrence in stage II colon cancer CNRS Inist Pascal-Francis CNRS Pascal and …
tumor recurrence in stage II colon cancer CNRS Inist Pascal-Francis CNRS Pascal and …
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
G Lurje, AE Hendifar, AM Schultheis… - Pharmacogenetics …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose Identifying molecular markers for tumor recurrence is critical in successfully
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
[PDF][PDF] Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
G Lurjea, AE Hendifara, AM Schultheisa, A Pohla… - researchgate.net
Purpose Identifying molecular markers for tumor recurrence is critical in successfully
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
G Lurje, AE Hendifar, AM Schultheis, A Pohl… - Pharmacogenetics …, 2009 - europepmc.org
Purpose Identifying molecular markers for tumor recurrence is critical in successfully
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …
selecting patients with stage II colon cancer who are more likely to benefit from adjuvant …